Shawn Cross, Chief Financial Officer at Pacira BioSciences, Inc. (PCRX), sold 12,941 shares at $25.16 ($326K) on 2026-04-23, disclosed to the SEC on 2026-04-24.
Scheduled sale ($326k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2025-11-13 | $533K | — | Filing → |
| AMTI | SELL | 2023-11-24 | $18K | — | Filing → |
| AMTI | SELL | 2023-11-16 | $14K | — | Filing → |